Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Isabelle Arnet, Sabrina Schacher, Eva Balmer, Dieter Koeberle & Kurt E Hersberger. (2016) Poor adhesion of fentanyl transdermal patches may mimic end-of-dosage failure after 48 hours and prompt early patch replacement in hospitalized cancer pain patients. Journal of Pain Research 9, pages 993-999.
Read now
Read now
Articles from other publishers (21)
Serena Montanari, Lara Davani, Cristina Terenzi, Marco Maltoni, Vincenza Andrisano, Angela De Simone & Marianna Ricci. (2022) Fentanyl pharmacokinetics in blood of cancer patients by Gas Chromatography – Mass Spectrometry. Journal of Pharmaceutical and Biomedical Analysis 219, pages 114913.
Crossref
Crossref
Lewis Thomas Hughes, David Raftery, Paul Coulter, Barry Laird & Marie Fallon. (2022) Use of opioids in patients with cancer with hepatic impairment—a systematic review. BMJ Supportive & Palliative Care 12:2, pages 152-157.
Crossref
Crossref
Soo Hyeon Shin, Mingming Yu, Dana C. Hammell, Priyanka Ghosh, Sam G. Raney, Hazem E. Hassan & Audra L. Stinchcomb. (2022) Evaluation of in vitro/in vivo correlations for three fentanyl transdermal delivery systems using in vitro skin permeation testing and human pharmacokinetic studies under the influence of transient heat application. Journal of Controlled Release 342, pages 134-147.
Crossref
Crossref
Aymen A. Al-Qurain, Richard Upton, Desmond B. Williams, Lorraine Mackenzie, Craig Phillips, Patrick T. Russell, Rami Tadros, Michael S. Roberts & Michael D. Wiese. (2021) Population pharmacokinetic model of subcutaneous fentanyl in older acute care patients. European Journal of Clinical Pharmacology 77:9, pages 1357-1368.
Crossref
Crossref
O. P. Bobrova, N. A. Shnayder, M. M. Petrova, S. N. Zobova, Yu. A. Dykhno, S. K. Zyryanov, A. V. Bobrov, R. F. Nasyrova, L. V. Lipinskiy, A. S. Polyakova & O. D. Melnikova. (2021) Predicting of fentanyl-associated neurotoxicity in pancreatic cancer with clical, genetic model. Experimental and Clinical Gastroenterology:3, pages 136-145.
Crossref
Crossref
Kyle T. Herndon, Kate S. Claussen & Jason J. Braithwaite. (2020) A Novel Clinical Consideration to Conserve Parenteral Fentanyl During the COVID-19 Pandemic. Anesthesia & Analgesia 131:5, pages 1355-1357.
Crossref
Crossref
Natalie Moryl, Ali Bokhari, Yvona Griffo, Rachel Hadler, Lauren Koranteng, Alexandra Filkins, Tianyu Zheng, Susan D. Horn & Charles E. Inturrisi. (2019) Does transdermal fentanyl work in patients with low BMI? Patient‐reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanyl. Cancer Medicine 8:18, pages 7516-7522.
Crossref
Crossref
Maurice Wilde, Simona Pichini, Roberta Pacifici, Adriano Tagliabracci, Francesco Paolo Busardò, Volker Auwärter & Renata Solimini. (2019) Metabolic Pathways and Potencies of New Fentanyl Analogs. Frontiers in Pharmacology 10.
Crossref
Crossref
Tony Priestley, Arvind K Chappa, Diane R Mould, Richard N Upton, Neil Shusterman, Steven Passik, Vicente J Tormo & Stephen Camper. (2018) Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers. Pain Medicine 19:10, pages 1988-1996.
Crossref
Crossref
O. P. Bobrova, Y. A. Dyhno, N. A. Shnayder, M. M. Petrova & S. K. Zyryanov. (2018) PHARMACOKINETIC AND PHARMACOGENETIC ASPECTS OF PERSONALIZED ANALGETIC THERAPY WITH FENTANIL TTS IN CLINICAL ONCOLOGY. Siberian journal of oncology 17:3, pages 94-100.
Crossref
Crossref
Evelien J. M. Kuip, Wendy H. Oldenmenger, Martine F. Thijs—Visser, Peter de Bruijn, Astrid W. Oosten, Esther Oomen—de Hoop, Stijn L. W. Koolen, Carin C. D. Van der Rijt & Ron H. J. Mathijssen. (2018) Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer. PLOS ONE 13:6, pages e0198289.
Crossref
Crossref
Evelien J.M. Kuip, Wendy H. Oldenmenger, Martine F. Visser-Thijs, Peter de Bruijn, Esther Oomen-de Hoop, Ron H.J. Mathijssen, Carin C.D. Van der Rijt & Stijn W. Koolen. (2018) Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl. Oncotarget 9:26, pages 18269-18276.
Crossref
Crossref
Harm Westdorp, Evelien J.M. Kuip, Inge M. van Oort, Cornelis Kramers, Winald R. Gerritsen & Kris C.P. Vissers. (2018) Difficulties in Pain Management Using Oxycodone and Fentanyl in Enzalutamide-Treated Patients With Advanced Prostate Cancer. Journal of Pain and Symptom Management 55:4, pages e6-e8.
Crossref
Crossref
Matthew W. Linakis, Joseph E. Rower, Jessica K. Roberts, Eleanor I. Miller, Diana G. Wilkins & Catherine M. T. Sherwin. (2017) Population pharmacokinetic model of transdermal nicotine delivered from a matrix‐type patch. British Journal of Clinical Pharmacology 83:12, pages 2709-2717.
Crossref
Crossref
Evelien J. M. Kuip, Maarten L. Zandvliet, Stijn L. W. Koolen, Ron H. J. Mathijssen & Carin C. D. van der Rijt. (2016) A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients. British Journal of Clinical Pharmacology 83:2, pages 294-313.
Crossref
Crossref
Takuya Ishida, Takafumi Naito, Hikaru Sato & Junichi Kawakami. (2016) Relationship between the plasma fentanyl and serum 4β-hydroxycholesterol based on CYP3A5 genotype and gender in patients with cancer pain. Drug Metabolism and Pharmacokinetics 31:3, pages 242-248.
Crossref
Crossref
Sudeep R. Bista, Alison Haywood, Janet Hardy, Ross Norris & Stefanie Hennig. (2016) Exposure to Fentanyl After Transdermal Patch Administration for Cancer Pain Management. The Journal of Clinical Pharmacology 56:6, pages 705-713.
Crossref
Crossref
Astrid W. Oosten, Jo?o A. Abrantes, Siv J?nsson, Peter de Bruijn, Evelien J. M. Kuip, Am?lcar Falc?o, Carin C. D. van der Rijt & Ron H. J. Mathijssen. (2016) Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients. European Journal of Clinical Pharmacology 72:4, pages 459-467.
Crossref
Crossref
Sebastiano Mercadante. (2015) Opioid metabolism and clinical aspects. European Journal of Pharmacology 769, pages 71-78.
Crossref
Crossref
Hee Youn Choi, Yo Han Kim, Donghyun Hong, Seong Su Kim, Kyun-Seop Bae & Hyeong-Seok Lim. (2015) Therapeutic dosage assessment based on population pharmacokinetics of a novel single-dose transdermal donepezil patch in healthy volunteers. European Journal of Clinical Pharmacology 71:8, pages 967-977.
Crossref
Crossref
Daniel T. Barratt, Benedikte Bandak, Pål Klepstad, Ola Dale, Stein Kaasa, Lona L. Christrup, Jonathan Tuke & Andrew A. Somogyi. (2014) Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study. Pharmacogenetics and Genomics 24:4, pages 185-194.
Crossref
Crossref